pharmaphorum

MARCH 1, 2022

This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines).

Vaccines 96

Vaccines Hospitals 96

Hospital Pharmacy Europe

MARCH 11, 2025

of NIHR Doctoral Fellowship applications between 2014 and 2021 came from pharmacy professionals. According to Professor Debi Bhattacharya, professor of behavioural medicines at the University of Leicesters School of Allied Health Professions, who is leading the Incubator project, only 2.7%

Hospitals 80

Hospitals Patient Care Labelling Vaccines 80

PharmExec

MARCH 13, 2024

Data shows that from 2014-2019, pneumococcal vaccinations in seniors increased by 10%, growing sales for Prevnar 13 due to government recommendation in addition to a high-profile advertising campaign.

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

Vaccines 98

Vaccines 98

pharmaphorum

JANUARY 30, 2022

The debut was the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014, and followed a £195 million fundraising round for Oxford Nanopore in May. The Oxford University spin-out rose to prominence for commercialising the technology platform behind the Oxford/AstraZeneca COVID-19 vaccine.

Vaccines 98

Vaccines 98

pharmaphorum

FEBRUARY 14, 2022

In a recent report by Deloitte, however, the continual decline in return on R&D investment from 2014 was reversed in a minor way in 2020, followed by a significant improvement in 2021. As a result, the internal rate of return on investment is as high in 2021 as it has been across the industry since 2014. More than meets the eye.

Vaccines 98

Vaccines 98

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 In April 2008, AstraZeneca also reached an agreement with Ranbaxy, an Indian generic drugmaker, allowing it to produce a generic version of Nexium starting in May 2014. Pfizer makes its move.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

pharmaphorum

NOVEMBER 16, 2020

In his final message as head of the EMA, Rasi said the number of COVID-19 drugs and vaccines being developed by pharma companies is “encouraging,” and pointing to the agency’s pivotal role “in reviewing the available data packages to ensure that our usual high standards of safety, efficacy and quality are achieved and upheld.”.

Vaccines 64

Vaccines Packaging FDA 64

European Pharmaceutical Review

MARCH 1, 2023

Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine. 2014 Nov 20; 56(4), 506‑17.

Vaccines 111

Vaccines Packaging 111

Pharmaceutical Technology

SEPTEMBER 5, 2022

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We We want to be a sustainably growing company. billion in development.

FDA 114

FDA Vaccines 114

pharmaphorum

OCTOBER 24, 2022

Exemptions include exceptional central procurements, centrally procured vaccines, small company sales, and low-value sales (when the NHS list price is less than £2). The PPRS changed over time, and the 2014 PPRS first introduced a cap to NHS branded medicines spending delivered via rebates. No mention of the CDF is in the annexes.

Vaccines 75

Vaccines 75

Pharmaceutical Technology

NOVEMBER 22, 2022

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long and complex process taking up to a decade. Before COVID-19, Merck held the record for the fastest modern vaccine ever developed. mRNA’s potential for rapid vaccine delivery.

Vaccines 52

Vaccines Immunization FDA 52

pharmaphorum

OCTOBER 1, 2021

It also won a £113 million contract to provide rapid saliva-based COVID-19 testing services to the NHS, although that was ended early by the UK government in the summer as demand fell due to vaccinations.

Documentation 52

Documentation Vaccines 52

pharmaphorum

SEPTEMBER 21, 2020

AstraZeneca may have had a rough ride following a safety scare with its COVID-19 vaccine, but the company’s busy pipeline is producing successes in other areas. Lynparza was the first PARP (poly (ADP-ribose) polymerase) drug on the market in 2014, first approved in the US for ovarian cancer. months versus 17.7

Labelling 52

Labelling Vaccines FDA 52

Hospital Pharmacy Europe

AUGUST 21, 2023

And we should draw on our experience with Covid-19 to build the ‘toolbox’ for tackling antimicrobial resistance which will include work on diagnostics, surveillance, therapeutics and vaccines, the summary of consultation feedback said. The Government’s National Action Plan goal was to reduce prescribing by 15% by 2024 from a 2014 baseline.

Hospitals 52

Hospitals Vaccines 52

PQA

NOVEMBER 16, 2023

Here are the PQA Executive Fellowship alumni and where they are today: Laurin Dixon, PharmD, Lead Executive, Medicare Products, Arkansas Blue Cross and Blue Shield (2013-2014 Executive Fellow) Maria Scarlatos Eid, PharmD, CPHQ, Global Professional Relations & Independent Medical Education, Vaccines, Merck (2014-2015 Executive Fellow) Hannah (..)

Vaccines 45

Vaccines 45

pharmaphorum

DECEMBER 2, 2020

In 2014 the company made an offer of around $100 billion to acquire UK firm AstraZeneca (which at the time was going through a rough patch ). The $12 billion deal was cleared in November 2020, creating a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

The Checkup by Singlecare

OCTOBER 26, 2023

Key takeaways: Left arm pain is a common symptom that may be caused by an injury, vaccines, medications, or more severe conditions such as a heart attack. Recent vaccines may contribute to the causes of arm pain. Any vaccine may cause arm pain, according to the United States Centers for Disease Control and Prevention (CDC).

Vaccines 52

Vaccines Hospitals 52

pharmaphorum

JULY 14, 2021

In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

European Pharmaceutical Review

JANUARY 29, 2024

Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed. EMA initiatives for acceleration of development support and evaluation procedures for COVID-19 treatments and vaccines [OBSOLETE].

FDA 111

FDA Vaccines Compounding 111

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines 97

Vaccines Compounding Documentation FDA 97

pharmaphorum

MAY 25, 2021

She went on to describe another study, EAVE II , which has drawn on BREATHE’s expertise, linking patient data across the entire Scottish population to provide the first real-world evidence of the success of the COVID-19 vaccination programme in cutting risk of hospital admission. About Savana.

Hospitals 104

Hospitals Vaccines 104

The FDA Law Blog

JANUARY 7, 2024

To better understand FDA’s approach in classifying postmarketing pregnancy studies as PMRs or PMCs, we reviewed all postmarketing requirements (PMRs) and postmarketing commitments (PMCs) related to maternal and fetal outcomes in FDA’s PMR/PMC database for drugs approved in the ten-year period from January 2014 through December 2023.

FDA 59

FDA Documentation Vaccines 59

European Pharmaceutical Review

JUNE 27, 2023

About the interviewees Hervé Affagard is the CEO and co-founder of MaaT Pharma, which was established in late 2014. He has also held the role of Vice President and Therapeutic Area Head, Vaccine Clinical Research at Merck & Co. For the past 15 years, Hervé has been an intra/entrepreneur in the healthcare industry.

Chemotherapy 105

Chemotherapy Immunization FDA Vaccines 105

Hospital Pharmacy Europe

NOVEMBER 23, 2023

The statements, which were adopted in 2014, express commonly agreed objectives which every European health system should aim for in the delivery of hospital pharmacy services. Looking forwards, the report concluded that further work is needed to support the development of hospital pharmacists in clinical service provision.

Hospitals 52

Hospitals Compounding Patient Care Vaccines 52

pharmaphorum

MAY 20, 2022

She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines). Sheena has a wealth of experience of managing and delivering clinical trials.

Hospitals 59

Hospitals Medical Records Vaccines 59

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. By 2016, Gilead already had competition for the HCV market, when MSD launched their product at €47,000 per treatment.

Insurance 52

Insurance Vaccines 52

ISPE

MAY 9, 2023

Jaguar Gene Therapy is building a $125 million facility in RTP to manufacture adeno-associated virus (AAV)-based gene therapies, Beam Therapeutics is constructing an $83 million plant to develop precision medicines, and IQVIA, a CRO, opened an innovation lab in the park in 2021, focusing on bioanalytics, vaccines, biomarkers, and genomics.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

ISPE

MARCH 8, 2023

Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S. In the Moderna COVID-19 vaccine contamination case, three lots of the five lots affected, totaling 1.63 How Did 75M J&J Vaccines Get Ruined?

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

PharmaShots

APRIL 13, 2023

and became a leader in the medical device industry Novartis raised its sales by 16% and acquired Alcon (ophthalmic business), Genoptix (oncology business), and an 85% stake in Zhejiang Tianyuan (vaccine business) Bayer recorded a revenue of $49B as its pharmaceutical business posted an encouraging performance in the emerging market.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

pharmaphorum

SEPTEMBER 9, 2021

COVID-19 also put global supply chains in the spotlight, as industry looked to remove obstacles and speed the delivery of material crucial to vaccine development processes. The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development.

Patient Care 52

Patient Care Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

SEPTEMBER 11, 2023

Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” www.fiercepharma.com/manufacturing/sanofi-pumps-554m-into-new-vaccine-manufacturing-facility-eastern-france 41 Boccard. New Project: Evolutive Vaccines Facility for Sanofi.” www.boccard.com/evolutive-vaccines-facility-for-sanofi/ 42 Amgen.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

PharmaShots

JANUARY 31, 2023

The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. Founded Year: 2014 No. Funding Value: $15.9M Founded Year: 2007 No. of Shares: 3.7M

Vaccines 40

Vaccines Immunization FDA 40

PharmaShots

FEBRUARY 21, 2023

Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines. Under its radiopharmaceutical segment, OncoTherapy is developing OTSA101, an anti-FZD10 antibody that specifically binds to FZD10 in cancer cells.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

The Checkup by Singlecare

JULY 31, 2024

Gardasil 9 isn’t just for girls and women; boys and men can benefit from this vaccine too. In 2014, the Food and Drug Administration (FDA) approved Gardasil 9 for females between the ages of 9 and 26 and males between the ages of 9 and 15. Given these updates, many people are now eligible for the vaccine.

Dosage 97

Dosage Vaccines Insurance Immunization 97

pharmaphorum

JUNE 10, 2021

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 105